{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:06:08Z","timestamp":1790352368793,"version":"4.1.0"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T00:00:00Z","timestamp":1645142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Charcot neuropathic osteoarthropathy (CN) is a serious and potentially limb-threatening complication for patients with diabetes mellitus and peripheral arterial disease. In recent decades, nuclear medicine-based approaches have been used for non-invasive detection of CN; however, to date, a positron emission tomography (PET) radionuclide specifically focused on targeted imaging of active bone remodeling has not been explored or validated for patients with CN. The radionuclide <jats:sup>18<\/jats:sup>F-sodium fluoride (NaF) has historically been used as a bone imaging probe due to its high sensitivity for targeting hydroxyapatite and bone turnover, but has not been applied in the context of CN. Therefore, the present study focused on novel application of <jats:sup>18<\/jats:sup>F-NaF PET\/computed tomography (CT) imaging to three clinical cases of CN to evaluate active bone remodeling at various time courses of CN. PET\/CT imaging in all 3 cases demonstrated focal uptake of <jats:sup>18<\/jats:sup>F-NaF in the bones of the feet afflicted with CN, with bone retention of <jats:sup>18<\/jats:sup>F-NaF persisting for up to 5 years following surgical reconstruction of the foot in two cases. On a group level, <jats:sup>18<\/jats:sup>F-NaF bone uptake in the CN foot was significantly higher compared to the healthy, non-CN foot (<jats:italic>p<\/jats:italic> = 0.039). <jats:sup>18<\/jats:sup>F-NaF PET\/CT imaging may provide a non-invasive tool for monitoring active bone remodeling in the setting of CN, thereby offering novel opportunities for tracking disease progression and improving treatment and surgical intervention.<\/jats:p>","DOI":"10.3389\/fmed.2022.795925","type":"journal-article","created":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T07:32:50Z","timestamp":1645169570000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Novel Application of 18F-NaF PET\/CT Imaging for Evaluation of Active Bone Remodeling in Diabetic Patients With Charcot Neuropathy: A Proof-of-Concept Report"],"prefix":"10.3389","volume":"9","author":[{"given":"Nguyen K.","family":"Tram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Heng","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surina","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila N.","family":"Ettefagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said A.","family":"Atway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchel R.","family":"Stacy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1053\/j.jfas.2019.08.039","article-title":"Complications of Charcot reconstruction in patients with peripheral arterial disease","volume":"60","author":"Cates","year":"2021","journal-title":"J Foot Ankle Surg"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1177\/15347346211025893.","article-title":"Incidence and predictive factors for amputations derived from Charcot's neuroarthropathy in persons with diabetes","author":"Bandeira","year":"2021","journal-title":"Int J Low Extrem Wounds"},{"key":"B3","doi-asserted-by":"publisher","first-page":"696","DOI":"10.2106\/JBJS.17.00785","article-title":"Charcot neuroarthropathy of the foot and ankle","volume":"100","author":"Dodd","year":"2018","journal-title":"J Bone Joint Surg Am."},{"key":"B4","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jcot.2020.03.025","article-title":"Charcot foot reconstruction outcomes: a systematic review","volume":"11","author":"Ha","year":"2020","journal-title":"J Clin Orthop Trauma."},{"key":"B5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13244-019-0768-9","article-title":"The Charcot foot: a pictorial review","volume":"10","author":"Rosskopf","year":"2019","journal-title":"Insights Imaging."},{"key":"B6","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jdiacomp.2011.02.001","article-title":"The importance of limb preservation in the diabetic population","volume":"25","author":"Evans","year":"2011","journal-title":"J Diabetes Complications."},{"key":"B7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/(SICI)1096-9136(199801)15:1<80::AID-DIA517>3.0.CO;2-K","article-title":"Evaluation of a diabetic foot screening and protection programme","volume":"15","author":"McCabe","year":"1998","journal-title":"Diabet Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"21884","DOI":"10.3402\/dfa.v4i0.21884","article-title":"Charcot foot in diabetes and an update on imaging","volume":"4","author":"Ergen","year":"2013","journal-title":"Diabet Foot Ankle."},{"key":"B9","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1055\/s-2005-921945","article-title":"Differential diagnosis of pedal osteomyelitis and diabetic neuroarthropathy: MR imaging","volume":"9","author":"Ledermann","year":"2005","journal-title":"Semin Musculoskelet Radiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1177\/1071100716672660","article-title":"Diagnostic imaging of diabetic foot disorders","volume":"38","author":"Peterson","year":"2017","journal-title":"Foot Ankle Int."},{"key":"B11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1302\/0301-620X.78B1.0780051","article-title":"Diagnosis of osteomyelitis in neuropathic foot ulcers","volume":"78","author":"Crerand","year":"1996","journal-title":"J Bone Joint Surg Br."},{"key":"B12","first-page":"1651","article-title":"Combined bone scintigraphy and indium-111 leukocyte scans in neuropathic foot disease","volume":"29","author":"Schauwecker","year":"1988","journal-title":"J Nucl Med."},{"key":"B13","first-page":"485","article-title":"Diagnosis of osteomyelitis in the diabetic foot with a 99mTc-HMPAO leucocyte scintigraphy combined with a 99mTc-MDP bone scintigraphy","volume":"28","author":"Poirier","year":"2002","journal-title":"Diabetes Metab."},{"key":"B14","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1148\/rg.263055139","article-title":"Combined labeled leukocyte and technetium 99m sulfur colloid bone marrow imaging for diagnosing musculoskeletal infection","volume":"26","author":"Palestro","year":"2006","journal-title":"Radiographics."},{"key":"B15","first-page":"346","article-title":"Marrow versus infection in the Charcot joint: indium-111 leukocyte and technetium-99m sulfur colloid scintigraphy","volume":"39","author":"Palestro","year":"1998","journal-title":"J Nucl Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/00003072-199204000-00001","article-title":"Diagnosis of musculoskeletal infection using combined in-111 labeled leukocyte and Tc-99m Sc marrow imaging","volume":"17","author":"Palestro","year":"1992","journal-title":"Clin Nucl Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/MNM.0b013e328174447f","article-title":"Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft-tissue infection?","volume":"28","author":"Basu","year":"2007","journal-title":"Nucl Med Commun."},{"key":"B18","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1177\/107110070402501208","article-title":"Preoperative imaging of Charcot neuroarthropathy in diabetic patients: comparison of ring PET, hybrid PET, and magnetic resonance imaging","volume":"25","author":"Hopfner","year":"2004","journal-title":"Foot Ankle Int."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1097\/MNM.0000000000000603","article-title":"Utility of PET\/CT with fluorine-18-fluorodeoxyglucose-labeled autologous leukocytes for diagnosing diabetic foot osteomyelitis in patients with Charcot's neuroarthropathy","volume":"37","author":"Rastogi","year":"2016","journal-title":"Nucl Med Commun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/RLU.0b013e318292eecb","article-title":"A new natural history of charcot foot clinical evolution and final outcome of stage 0 charcot neuroarthropathy in a tertiary referral diabetic foot clinic","volume":"38","author":"Ruotolo","year":"2013","journal-title":"Clin Nucl Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.2967\/jnumed.110.077933","article-title":"Molecular mechanisms of bone 18F-NaF deposition","volume":"51","author":"Czernin","year":"2010","journal-title":"J Nucl Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4103\/1450-1147.174698","volume":"15","author":"Mabray","year":"2016","journal-title":"World J Nucl Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00774-019-01059-z","volume":"38","author":"Graf","year":"2020","journal-title":"J Bone Miner Metab."},{"key":"B24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jbo.2015.08.002","article-title":"The role of 18F-NaF PET\/CT in metastatic bone disease","volume":"4","author":"Araz","year":"2015","journal-title":"J Bone Oncol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s11307-019-01425-3","article-title":"Clinical applications for radiotracer imaging of lower extremity peripheral arterial disease and critical limb ischemia","volume":"22","author":"Chou","year":"2020","journal-title":"Mol Imaging Biol."},{"key":"B26","unstructured":"2021"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.795925\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T07:32:57Z","timestamp":1645169577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.795925\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,18]]},"references-count":26,"alternative-id":["10.3389\/fmed.2022.795925"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.795925","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,18]]},"article-number":"795925"}}